Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial stages of rejuvenation of vapor-deposited glasses during isothermal annealing: Contrast between experiment and simulation.

The Journal of chemical physics·2024
Same author

Gestational breast cancer: distinctive molecular and clinico-epidemiological features.

Journal of mammary gland biology and neoplasia·2024
Same author

What is the degree of variability in formal training for pediatric orthopedic surgeons performing scoliosis surgery?

Acta ortopedica mexicana·2023
Same author

Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer.

Scientific reports·2021
Same author

Surgical approach significantly affects the complication rates associated with total hip arthroplasty.

The bone & joint journal·2019
Same author

Reduction of a tris(picolyl)amine copper(ii) complex by a polymeric flavo-reductase model in water.

Dalton transactions (Cambridge, England : 2003)·2016

Related Experiment Video

Updated: May 20, 2026

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
08:53

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

New developments in erythropoietic porphyrias.

E Darwich1, C Herrero

  • 1Departamento de Dermatología, Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Spain. chevedarwich@yahoo.es

Actas Dermo-Sifiliograficas
|July 7, 2012
PubMed
Summary

Recent genetic discoveries reveal porphyrias like EPP and CEP are not strictly monogenic. Identifying novel gene mutations explains patient variability and aids in diagnosing previously unexplained cases.

More Related Videos

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay
15:32

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay

Published on: August 5, 2011

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis
06:40

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis

Published on: September 9, 2014

Related Experiment Videos

Last Updated: May 20, 2026

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo
08:53

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

Published on: January 10, 2025

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay
15:32

Identification and Analysis of Mouse Erythroid Progenitors using the CD71/TER119 Flow-cytometric Assay

Published on: August 5, 2011

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis
06:40

Mouse Fetal Liver Culture System to Dissect Target Gene Functions at the Early and Late Stages of Terminal Erythropoiesis

Published on: September 9, 2014

Area of Science:

  • Genetics
  • Biochemistry
  • Molecular Biology

Background:

  • Porphyrias, specifically erythropoietic protoporphyria (EPP) and congenital erythropoietic porphyria (CEP), were traditionally viewed as monogenic disorders.
  • Recent research indicates a more complex genetic basis for these conditions.

Purpose of the Study:

  • To elucidate the genetic underpinnings of EPP and CEP beyond single-gene mutations.
  • To explain genotypic and phenotypic variations among patients with porphyrias.
  • To identify causative genetic defects in patients lacking mutations in known genes (UROS for CEP, FECH for EPP).

Main Methods:

  • Genetic sequencing and mutation analysis.
  • Identification of novel causative genes and genetic modulators.
  • Comparative analysis of genotypic and phenotypic data.

Main Results:

  • Advances in understanding the genetics of porphyrias, particularly EPP and CEP.
  • Identification of mutations in previously unassociated genes as causative or severity-modulating factors.
  • Discovery of genetic defects in patients negative for UROS or FECH mutations.

Conclusions:

  • EPP and CEP are not solely monogenic, with multiple genes influencing their expression.
  • Understanding these complex genetic interactions is crucial for accurate diagnosis and prognosis.
  • Improved molecular classification of porphyrias based on comprehensive genetic characterization is needed.